TCRT
Alaunos Therapeutics
$1.93
−$0.01 (−0.52%)Jul 27, 2026
Key metrics
The numbers that frame TCRT today
- Market cap
- $4.59M
- P/E (TTM)
- -1.1
- EV / FCF
- -1.4
- Gross margin
- 100%
- EV / Sales
- 1,412.0
- ROIC
- -490.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.67
- 52wk High
- $4.59
Growth
Revenue and earnings trend for TCRT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TCRT
Is Alaunos Therapeutics a good buy?
No. Alaunos Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Alaunos Therapeutics is selling at a very high price.
What is the market capitalization of TCRT?
Alaunos Therapeutics's market capitalization is $4.59M.
What is the P/E ratio for TCRT stock?
Alaunos Therapeutics's current P/E ratio is -1.1.
What is the 52-week high for TCRT stock?
The 52-week high for Alaunos Therapeutics is $4.59. The current close of $1.93 is 58% below that high.
What is the 52-week low for TCRT stock?
The 52-week low for Alaunos Therapeutics is $1.67. The current close of $1.93 is 15.6% above that low.
Does TCRT stock pay dividends?
Alaunos Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TCRT?
Alaunos Therapeutics's Debt / Equity ratio is 0.